Aschan, J <br/><br/>
Improved survival after bone marrow transplantation for early leukemia using busulfan-cyclophosphamide and individualized prophylaxis against graft-versus-host disease: a long-term follow-up.  [electronic resource] 

 -  Clinical transplantation  Dec 1999 
 - 512-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0902-0063 
<br/><br/><label>Standard No.: </label>10.1034/j.1399-0012.1999.130612.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Bone Marrow Transplantation<br/>Busulfan--therapeutic use<br/>Cyclophosphamide--therapeutic use<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Graft vs Host Disease--mortality<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Leukemia--mortality<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Survival Rate<br/>Time Factors